235 related articles for article (PubMed ID: 9387136)
1. Effects of protease therapy in the remnant kidney model of progressive renal failure.
Sebekova K; Paczek L; Dämmrich J; Ling H; Spustova V; Gaciong Z; Heidland A
Miner Electrolyte Metab; 1997; 23(3-6):291-5. PubMed ID: 9387136
[TBL] [Abstract][Full Text] [Related]
2. Protease administration decreases enhanced transforming growth factor-beta 1 content in isolated glomeruli of diabetic rats.
Paczek L; Gaciong Z; Bartlomiejczyk I; Sebekova K; Birkenmeier G; Heidland A
Drugs Exp Clin Res; 2001; 27(4):141-9. PubMed ID: 11822224
[TBL] [Abstract][Full Text] [Related]
3. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
4. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
Song J; Meng L; Li S; Qu L; Li X
Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
[TBL] [Abstract][Full Text] [Related]
5. Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction.
Quiroz Y; Ferrebuz A; Romero F; Vaziri ND; Rodriguez-Iturbe B
Am J Physiol Renal Physiol; 2008 Feb; 294(2):F336-44. PubMed ID: 18077597
[TBL] [Abstract][Full Text] [Related]
6. Effects of chronic administration of somatostatin analogue SMS 201-995 on the progression of chronic renal failure in subtotal nephrectomized rats.
Uemasu J; Tokumoto A; Godai K; Kawasaki H; Hirayama C
Exp Clin Endocrinol; 1990 Sep; 96(1):97-104. PubMed ID: 2279532
[TBL] [Abstract][Full Text] [Related]
7. Pirfenidone prevents collagen accumulation in the remnant kidney in rats with partial nephrectomy.
Shimizu T; Fukagawa M; Kuroda T; Hata S; Iwasaki Y; Nemoto M; Shirai K; Yamauchi S; Margolin SB; Shimizu F; Kurokawa K
Kidney Int Suppl; 1997 Dec; 63():S239-43. PubMed ID: 9407470
[TBL] [Abstract][Full Text] [Related]
8. Citrate attenuates tubulointerstitial fibrosis in 5/6 nephrectomized rats by decreasing transforming growth factor-beta1.
Manotham K; Eiam-Ong S; Eiam-Ong S; Wannakrairot P; Praditpornsilpa K; Chusil S; Tungsanga K
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S168-77. PubMed ID: 17044470
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody 1-22-3-induced glomerulonephritis in uninephrectomized rats as a model of progressive renal failure.
Tomita M; Sogabe H; Nakazato S; Nakatsuji S; Noto T; Hamada K; Kawachi H; Shimizu F; Matsuo M; Mutoh S
Nephrol Dial Transplant; 2005 Nov; 20(11):2358-67. PubMed ID: 16091375
[TBL] [Abstract][Full Text] [Related]
10. A re-evaluation of the renal ablation model of progressive renal disease in rats.
Kim KH; Kim Y; Park HW; Jeong HJ; Mauer M
J Nephrol; 2003; 16(2):196-202. PubMed ID: 12768066
[TBL] [Abstract][Full Text] [Related]
11. IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease.
Mu W; Ouyang X; Agarwal A; Zhang L; Long DA; Cruz PE; Roncal CA; Glushakova OY; Chiodo VA; Atkinson MA; Hauswirth WW; Flotte TR; Rodriguez-Iturbe B; Johnson RJ
J Am Soc Nephrol; 2005 Dec; 16(12):3651-60. PubMed ID: 16251240
[TBL] [Abstract][Full Text] [Related]
12. Oral carbonaceous absorbent modifies renal function of renal ablation model without affecting plasma renin-angiotensin system or protein intake.
Horike K; Usami T; Kamiya Y; Kamiya T; Yoshida A; Itoh S; Yamato H; Ise M; Kimura G
Clin Exp Nephrol; 2003 Jun; 7(2):120-4. PubMed ID: 14586730
[TBL] [Abstract][Full Text] [Related]
13. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
Omata M; Taniguchi H; Koya D; Kanasaki K; Sho R; Kato Y; Kojima R; Haneda M; Inomata N
J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498
[TBL] [Abstract][Full Text] [Related]
14. Renoprotective properties of pirfenidone in subtotally nephrectomized rats.
Takakuta K; Fujimori A; Chikanishi T; Tanokura A; Iwatsuki Y; Yamamoto M; Nakajima H; Okada M; Itoh H
Eur J Pharmacol; 2010 Mar; 629(1-3):118-24. PubMed ID: 20006961
[TBL] [Abstract][Full Text] [Related]
15. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of Hachimi-jio-gan against renal failure in a subtotal nephrectomy rat model.
Yamabe N; Yokozawa T; Kim HY; Cho EJ
J Pharm Pharmacol; 2005 Dec; 57(12):1637-44. PubMed ID: 16354408
[TBL] [Abstract][Full Text] [Related]
17. Effects of probucol in renal function and structure in rats with subtotal kidney ablation.
Modi KS; Schreiner GF; Purkerson ML; Klahr S
J Lab Clin Med; 1992 Aug; 120(2):310-7. PubMed ID: 1500828
[TBL] [Abstract][Full Text] [Related]
18. Renal effects of oral maillard reaction product load in the form of bread crusts in healthy and subtotally nephrectomized rats.
Sebeková K; Hofmann T; Boor P; Sebeková K; Ulicná O; Erbersdobler HF; Baynes JW; Thorpe SR; Heidland A; Somoza V
Ann N Y Acad Sci; 2005 Jun; 1043():482-91. PubMed ID: 16037270
[TBL] [Abstract][Full Text] [Related]
19. New approach for chronic renal failure model by direct kidney injection of doxorubicin in rats.
Yoneko M; Kamei J; Ito CF; Kojima J
Methods Find Exp Clin Pharmacol; 2007; 29(6):389-94. PubMed ID: 17922066
[TBL] [Abstract][Full Text] [Related]
20. Effect of propranolol on progression of chronic renal disease in partially nephrectomized rats.
Radin MJ; Wilke WL; Fettman MJ
Res Commun Chem Pathol Pharmacol; 1987 Jul; 57(1):3-13. PubMed ID: 3671878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
